Propanc Biopharma, Inc.

PPCB ·Healthcare, Drug Manufacturers - General, Australia
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-K Sep 25, 2026 10-K
DEF 14C Aug 21, 2026 DEF 14C
PRE 14C Aug 5, 2026 PRE 14C
EFFECT Jul 27, 2026
S-1 Jul 17, 2026 S-1
8-K Jul 14, 2026 8-K
10-Q May 14, 2026 10-Q
EFFECT Apr 20, 2026
CORRESP Apr 16, 2026
UPLOAD Apr 15, 2026
S-1 Apr 10, 2026 S-1
DEF 14C Mar 31, 2026 DEF 14C
PRE 14C Mar 20, 2026 PRE 14C
PRE 14A Mar 19, 2026 PRE 14A
424B3 Mar 6, 2026 424B3
8-K Feb 26, 2026 8-K
EFFECT Feb 24, 2026
CORRESP Feb 20, 2026
S-1/A Feb 19, 2026 S-1/A
10-Q Feb 17, 2026 10-Q
CORRESP Feb 12, 2026
CORRESP Feb 10, 2026
UPLOAD Feb 10, 2026
S-1 Feb 2, 2026 S-1
424B3 Jan 30, 2026 424B3
← Newer Page 1 of 18 · 434 filings Older →